Exact Mass: 331.0684

Exact Mass Matches: 331.0684

Found 61 metabolites which its exact mass value is equals to given mass value 331.0684, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2'-Deoxyadenosine 5'-phosphate

{[(2R,3S,5R)-5-(6-amino-9H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O6P (331.0682)


Deoxyadenosine monophosphate (dAMP), also known as deoxyadenylic acid or deoxyadenylate in its conjugate acid and conjugate base forms, respectively, is a derivative of the common nucleic acid AMP, or adenosine monophosphate, in which the -OH (hydroxyl) group on the 2 carbon on the nucleotides pentose has been reduced to just a hydrogen atom (hence the "deoxy-" part of the name). Additionally, the monophosphate of the name indicates that two of the phosphoryl groups of GTP have been removed, most likely by hydrolysis. It is a monomer used in DNA. Adenosine is a nucleoside comprised of adenine attached to a ribose (ribofuranose) moiety via a -N9-glycosidic bond. Acquisition and generation of the data is financially supported in part by CREST/JST. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1]. 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1].

   

Piroxicam

4-hydroxy-2-methyl-1,1-dioxo-N-(pyridin-2-yl)-2H-1λ⁶,2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


Piroxicam is only found in individuals that have used or taken this drug. It is a cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily. [PubChem]The antiinflammatory effect of Piroxicam may result from the reversible inhibition of cyclooxygenase, causing the peripheral inhibition of prostaglandin synthesis. The prostaglandins are produced by an enzyme called Cox-1. Piroxicam blocks the Cox-1 enzyme, resulting into the disruption of production of prostaglandins. Piroxicam also inhibits the migration of leukocytes into sites of inflammation and prevents the formation of thromboxane A2, an aggregating agent, by the platelets. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents KEIO_ID P068; [MS2] KO009199 D004791 - Enzyme Inhibitors KEIO_ID P068

   

2'-Deoxyadenosine 3'-monophosphate

{[5-(6-amino-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O6P (331.0682)


   

Fenbendazole sulfone

N-[6-(Benzenesulphonyl)-1H-1,3-benzodiazol-2-yl]methoxycarboximidic acid

C15H13N3O4S (331.0627)


   

Benzoic acid 2-(acetyloxy)-3-[(nitrooxy)methyl]phenyl ester

Benzoic acid 2-(acetyloxy)-3-[(nitrooxy)methyl]phenyl ester

C16H13NO7 (331.0692)


   

Cercosporamide

12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2(7),3,5,9,11-pentaene-6-carboxamide

C16H13NO7 (331.0692)


   

Nitroaspirin

2-Acetoxybenzoate-2-(1-nitroxymethyl)phenyl ester

C16H13NO7 (331.0692)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D018501 - Antirheumatic Agents

   

NO-aspirin

2-(ACETYLOXY)-4-[(NITROOXY)METHYL]PHENYL ESTER, BENZOIC ACID

C16H13NO7 (331.0692)


   

Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide

13-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0,]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.0724)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

N'-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

6-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.0724)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-methyl-1,1,4-trioxo-N-(pyridin-2-yl)-3,4-dihydro-2H-1lambda6,2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


   

Tibric acid

2-Chloro-5-[(3,5-dimethylpiperidin-1-yl)sulphonyl]benzoic acid

C14H18ClNO4S (331.0645)


   

Fenbendazole sulfone

Fenbendazole sulfone

C15H13N3O4S (331.0627)


   

Cercosporamide

Cercosporamide2-Hydroxycinnamic acidBenzoylaconine9-Dihydro-13-acetylbaccatin IIISanguinarine10-Deacetyl-7-xylosyl paclitaxelArecolineGinkgolide B2-Heptanol2,3-Pentanedione

C16H13NO7 (331.0692)


Cercosporamide is a member of the class of dibenzofurans that is a potent broad spectrum antifungal agent isolated from the fungus Cercosporidium henningsii. It has a role as an antifungal agent, a phytotoxin, a fungal metabolite and an EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor. It is a member of dibenzofurans, a polyphenol, a monocarboxylic acid amide and a methyl ketone. Cercosporamide is a natural product found in Clarohilum henningsii and Phoma with data available. Chlorinated dibenzofurans (CDFs) are a family of chemical that contain one to eight chlorine atoms attached to the carbon atoms of the parent chemical, dibenzofuran. The CDF family contains 135 individual compounds (known as congeners) with varying harmful health and environmental effects. Of these 135 compounds, those that contain chlorine atoms at the 2,3,7,8-positions of the parent dibenzofuran molecule are especially harmful. Other than for laboratory use of small amounts of CDFs for research and development purposes, these chemicals are not deliberately produced by industry. Most CDFs are produced in very small amounts as unwanted impurities of certain products and processes utilizing chlorinated compounds. Only a few of the 135 CDF compounds have been produced in large enough quantities so that their properties, such as color, smell, taste, and toxicity could be studied. (L952) A member of the class of dibenzofurans that is a potent broad spectrum antifungal agent isolated from the fungus Cercosporidium henningsii.

   

(R)-2-(2-Amino-O6-phosphono-2-desoxy-D-glucose-3-yloxy)-propionsaeure|2-Amino-O3-((R)-1-carboxy-aethyl)-O6-phosphono-2-desoxy-D-glucose|2-amino-O3-((R)-1-carboxy-ethyl)-O6-phosphono-2-deoxy-D-glucose|Muramsaeure-6-phosphat|O6-Phosphono-muramsaeure

(R)-2-(2-Amino-O6-phosphono-2-desoxy-D-glucose-3-yloxy)-propionsaeure|2-Amino-O3-((R)-1-carboxy-aethyl)-O6-phosphono-2-desoxy-D-glucose|2-amino-O3-((R)-1-carboxy-ethyl)-O6-phosphono-2-deoxy-D-glucose|Muramsaeure-6-phosphat|O6-Phosphono-muramsaeure

C9H18NO10P (331.0668)


   
   

5-Deoxymiriamide

5-Deoxymiriamide

C16H13NO7 (331.0692)


   
   
   

Deoxyadenosine monophosphate

2-DEOXYADENOSINE-5-monophosphoric acid

C10H14N5O6P (331.0682)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1]. 2′-Deoxyadenosine 5′-monophosphate, a nucleic acid AMP derivative, is a deoxyribonucleotide found in DNA. 2′-Deoxyadenosine 5′-monophosphate can be used to study adenosine-based interactions during DNA synthesis and DNA damage[1].

   

piroxicam

Piroxicam (Feldene)

C15H13N3O4S (331.0627)


A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylic acid 1,1-dioxide with the exocyclic nitrogen of 2-aminopyridine. A non-steroidal anti-inflammatory drug of the oxicam class, it is used to relieve pain and works by preventing the production of endogenous prostaglandins involved in the mediation of pain, stiffness, tenderness and swelling. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BC - Antiinflammatory agents, non-steroids D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

2-Deoxyadenosine-5-monophosphate

2-Deoxyadenosine-5-monophosphate

C10H14N5O6P (331.0682)


   

2-Deoxyadenosine 5-monophosphate

2-Deoxyadenosine 5-monophosphate

C10H14N5O6P (331.0682)


A purine 2-deoxyribonucleoside 5-monophosphate having adenine as the nucleobase.

   

2-Deoxyadenosine 5-phosphate

2-Deoxyadenosine 5-phosphate

C10H14N5O6P (331.0682)


   
   

SC-19220

8-chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxy-(2-acetyl)hydrazide

C16H14ClN3O3 (331.0724)


   

3-[3-(4-chlorophenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

3-[3-(4-chlorophenoxy)-2-oxopyrrolidin-1-yl]benzoic acid

C17H14ClNO4 (331.0611)


   

Nepicastat (hydrochloride)

Nepicastat (hydrochloride)

C14H16ClF2N3S (331.0721)


   

7-Methoxycoumarin-4-acetic acid N-succinimidyl ester

7-Methoxycoumarin-4-acetic acid N-succinimidyl ester

C16H13NO7 (331.0692)


   

7-Hydroxy-4-methylcoumarin-3-acetic acid, succinimidyl ester

7-Hydroxy-4-methylcoumarin-3-acetic acid, succinimidyl ester

C16H13NO7 (331.0692)


   

5-Bromo-2-((tert-Butyldimethylsilyloxy)methyl)-3-methoxypyridine

5-Bromo-2-((tert-Butyldimethylsilyloxy)methyl)-3-methoxypyridine

C13H22BrNO2Si (331.0603)


   

Glymidine sodium

Glymidine sodium

C13H14N3NaO4S (331.0603)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent

   

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate

1-(tert-Butoxycarbonyl)-1,2,3,6-tetrahydropyridin-4-yl trifluoromethanesulfonate

C11H16F3NO5S (331.0701)


   

3-(4-CHLORO-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

3-(4-CHLORO-BENZENESULFONYL)-AZETIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C14H18ClNO4S (331.0645)


   

2-deoxyadenosine 3-monophosphate

2-deoxyadenosine 3-monophosphate

C10H14N5O6P (331.0682)


   

5-(benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

5-(benzyloxy)-8-(2-chloroacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one

C17H14ClNO4 (331.0611)


   

Methyl 2-(2-(methoxycarbonyl)phenoxy)-5-nitrobenzoate

Methyl 2-(2-(methoxycarbonyl)phenoxy)-5-nitrobenzoate

C16H13NO7 (331.0692)


   

tert-butyl 5-(trifluoromethylsulfonyloxy)-3,6-dihydro-2H-pyridine-1-carboxylate

tert-butyl 5-(trifluoromethylsulfonyloxy)-3,6-dihydro-2H-pyridine-1-carboxylate

C11H16F3NO5S (331.0701)


   

3-INDOXYL-β-D-GLUCURONIC ACID, SODIUM SALT

3-INDOXYL-β-D-GLUCURONIC ACID, SODIUM SALT

C14H14NNaO7 (331.0668)


   

6-benzyloxy-8-(2-chloro-acetyl)-4H-benzo[1,4]oxazin-3-one

6-benzyloxy-8-(2-chloro-acetyl)-4H-benzo[1,4]oxazin-3-one

C17H14ClNO4 (331.0611)


   

3-Deoxyadenosine-5-monophosphate

3-Deoxyadenosine-5-monophosphate

C10H14N5O6P (331.0682)


   

2-Chloro-5-(3,5-dimethylpiperidinosulphonyl)benzoic acid

2-Chloro-5-(3,5-dimethylpiperidinosulphonyl)benzoic acid

C14H18ClNO4S (331.0645)


   

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-Methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-1$l^{6},2-benzothiazine-3-carboxamide

C15H13N3O4S (331.0627)


   

Glypinamide

Glypinamide

C13H18ClN3O3S (331.0757)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

4-[(4-bromophenyl)diazenyl]-N,N-diethylaniline

4-[(4-bromophenyl)diazenyl]-N,N-diethylaniline

C16H18BrN3 (331.0684)


   

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

C13H17NO7S (331.0726)


   

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

C16H15N2O4S- (331.0752)


   
   

2-(2-Chlorophenyl)-2-oxoethyl 3-(acetylamino)benzoate

2-(2-Chlorophenyl)-2-oxoethyl 3-(acetylamino)benzoate

C17H14ClNO4 (331.0611)


   

5-[(1,3-Benzodioxol-5-ylamino)methylidene]-1-cyclopropyl-2-sulfanylidene-1,3-diazinane-4,6-dione

5-[(1,3-Benzodioxol-5-ylamino)methylidene]-1-cyclopropyl-2-sulfanylidene-1,3-diazinane-4,6-dione

C15H13N3O4S (331.0627)


   

[(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate

[(2S,3R,4R)-4-(6-amino-9H-purin-9-yl)-3-(hydroxymethyl)oxetan-2-yl]methyl dihydrogen phosphate

C10H14N5O6P (331.0682)


   

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

C16H14ClN3O3 (331.0724)


   

(2Z)-2-[(2,4-dimethoxyphenyl)methylidene]-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazine-3,7-dione

(2Z)-2-[(2,4-dimethoxyphenyl)methylidene]-6-methyl-[1,3]thiazolo[3,2-b][1,2,4]triazine-3,7-dione

C15H13N3O4S (331.0627)


   

Nitroaspirin

Nitroaspirin

C16H13NO7 (331.0692)


D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D050299 - Fibrin Modulating Agents D002317 - Cardiovascular Agents D018501 - Antirheumatic Agents

   

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

C16H14ClN3O3 (331.0724)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

(1r)-12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

(1r)-12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

C16H13NO7 (331.0692)


   

12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

C16H13NO7 (331.0692)


   

1-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}-3-methylbutan-1-amine

1-{7-bromo-9h-pyrido[3,4-b]indol-1-yl}-3-methylbutan-1-amine

C16H18BrN3 (331.0684)


   

(2r)-2-{[(2r,3r,4r,5r)-2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

(2r)-2-{[(2r,3r,4r,5r)-2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

C9H18NO10P (331.0668)


   

2-{[2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

2-{[2-amino-4,5-dihydroxy-1-oxo-6-(phosphonooxy)hexan-3-yl]oxy}propanoic acid

C9H18NO10P (331.0668)


   

(1s)-12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

(1s)-12-acetyl-3,5,11-trihydroxy-1-methyl-13-oxo-8-oxatricyclo[7.4.0.0²,⁷]trideca-2,4,6,9,11-pentaene-6-carboximidic acid

C16H13NO7 (331.0692)